Health Policy最新文献_第7页

Public contributions to R&D of medical innovations: A framework for analysis 公众对医疗创新研发的贡献：分析框架。

IF 3.6 3区医学

Health Policy Pub Date : 2025-02-01 DOI: 10.1016/j.healthpol.2024.105235

Claudia Wild, Ozren Sehic, Louise Schmidt, Daniel Fabian

{"title":"Public contributions to R&D of medical innovations: A framework for analysis","authors":"Claudia Wild, Ozren Sehic, Louise Schmidt, Daniel Fabian","doi":"10.1016/j.healthpol.2024.105235","DOIUrl":"10.1016/j.healthpol.2024.105235","url":null,"abstract":"<div><h3>Background and Objective</h3><div>Article 57 of the proposed European Union (EU) Pharmaceutical Legislation (PL, Directive) will require market authorization applicants to publicly declare any direct financial support for R&D received from public authorities. Our research aims to identify the categories needed to capture direct or indirect public contributions to R&D, provide a framework for standardized reporting of public contributions, and reduce ambiguity in the interpretation of “direct” and “indirect” public contributions.</div></div><div><h3>Methods</h3><div>An iterative mixed-methods approach is applied: a targeted literature review was conducted, complemented by interviews with representatives of different stakeholder groups to identify categories of public contributions to R&D, followed by searches for relevant data sources.</div></div><div><h3>Results</h3><div>26 publications on primary data relevant to analyses of public contributions were identified, finding that between half of all drugs approved and >90 % of drug targets are associated with public sector institutions and/ or their spin-outs. Eight categories of public contributions to medical innovations were identified along the value chain (from basic research to post-market surveillance).</div></div><div><h3>Discussion and conclusion</h3><div>The framework offers a structured and systematic approach for identifying data on public and philanthropic contributions to developing medical products (medicines and devices). This information is often not comprehensively documented. Therefore, aligned public policies enforcing transparent and standardized reporting in sufficient granularity on R&D investments and conditions are key.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"152 ","pages":"Article 105235"},"PeriodicalIF":3.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142831014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Innovations in primary healthcare in Slovenia 2011–2020: Exploring the stepwise process behind effective implementation 2011-2020年斯洛文尼亚初级保健方面的创新：探索有效实施背后的逐步过程。

IF 3.6 3区医学

Health Policy Pub Date : 2025-02-01 DOI: 10.1016/j.healthpol.2024.105224

Katherine Polin , Giada Scarpetti , Pia Vracko

{"title":"Innovations in primary healthcare in Slovenia 2011–2020: Exploring the stepwise process behind effective implementation","authors":"Katherine Polin , Giada Scarpetti , Pia Vracko","doi":"10.1016/j.healthpol.2024.105224","DOIUrl":"10.1016/j.healthpol.2024.105224","url":null,"abstract":"<div><div>Countries worldwide seek to strengthen their primary healthcare systems often through introducing health promotion and disease prevention, multidisciplinary teams, group practices and community approaches to advance universal health coverage. These strategies are underpinned by scientific evidence and international standards. Slovenia's primary healthcare system reflects many of these features, with universally accessible, multidisciplinary, and integrated health services, emphasizing health promotion, disease prevention, and equity. Municipal primary healthcare centres serve as hubs within local communities. Slovenia's efforts to strengthen the delivery model are continuous and follow a controlled stepwise implementation process. This approach has strong policy support and organizational and implementation capacities.</div><div>This paper describes Slovenia's primary healthcare model and three innovations between 2011 and 2020: (1) family medicine model practices, (2) health promotion centres, and (3) mental health centres. These innovations are used both to showcase the efforts of Slovenia to enhance primary healthcare and as a lens to explore Slovenia's established primary healthcare innovation implementation approach. The three innovations have had a positive impact on health outcomes in the short- to medium-term, but mixed health system and implementation outcomes. Slovenia's experience can inspire other countries looking to sustainably integrate primary healthcare fully or effectively introduce single innovations in their primary healthcare systems.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"152 ","pages":"Article 105224"},"PeriodicalIF":3.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Policies and strategies to control antimicrobial resistance in livestock production: A comparative analysis of national action plans in European Union Member States 控制畜牧生产中抗菌素耐药性的政策和战略：欧洲联盟成员国国家行动计划的比较分析。

IF 3.6 3区医学

Health Policy Pub Date : 2025-02-01 DOI: 10.1016/j.healthpol.2024.105238

Caetano Luiz Beber , Maurizio Aragrande , Massimo Canali

{"title":"Policies and strategies to control antimicrobial resistance in livestock production: A comparative analysis of national action plans in European Union Member States","authors":"Caetano Luiz Beber , Maurizio Aragrande , Massimo Canali","doi":"10.1016/j.healthpol.2024.105238","DOIUrl":"10.1016/j.healthpol.2024.105238","url":null,"abstract":"<div><div>Policy strategies targeting imprudent antimicrobial use (AMU) in livestock farming have been established at the global and country levels, recognising the risks associated with antimicrobial resistance (AMR). This study evaluates the strategies addressing AMU and AMR in animal farms and the food supply chain in EU Member States using a multimethod approach. Our aim is to contribute to the debates surrounding the goals set by the EU Commission and the ‘Strategic framework for collaboration on antimicrobial resistance: Together for One Health’. We first review the policies, strategies and specific legislation in the European Union (EU) and Member States about AMU/AMR in livestock production. We then evaluate the national action plans for AMU reduction in the EU using the progressive management pathway tool from the FAO. Finally, we assess the measures that affect AMU reduction by applying a system generalised method of moments to a 8-year panel of the same countries. According to our results, efforts to reduce AMU could be focused on controlling excessive AMU in the pig sector. Further veterinary training on AMU/AMR and improvements in the performance of the veterinary sector, as well as strengthening the development of multisector and One Health collaboration and coordination, can also contribute to achieving better standards in AMU reduction in the livestock sector and, consequently, for AMR control.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"152 ","pages":"Article 105238"},"PeriodicalIF":3.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142900457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The 2017 reform to medical specialty training in Czechia: Exploring student career preferences

IF 3.6 3区医学

Health Policy Pub Date : 2025-01-28 DOI: 10.1016/j.healthpol.2025.105259

Lenka Šlegerová , Lucie Bryndová , Petr Michenka , Martin Kočí

{"title":"The 2017 reform to medical specialty training in Czechia: Exploring student career preferences","authors":"Lenka Šlegerová , Lucie Bryndová , Petr Michenka , Martin Kočí","doi":"10.1016/j.healthpol.2025.105259","DOIUrl":"10.1016/j.healthpol.2025.105259","url":null,"abstract":"<div><div>This article explores medical students’ career preferences in the context of the 2017 reform to medical specialty training in Czechia, which aimed to stabilise the physician workforce. One of the changes introduced by the reform was the merging of specialty training for both primary-care and hospital-based paediatrics, facilitating easier transitions of physicians between hospital and outpatient settings. This article presents findings from a survey, conducted by the authors in 2020–2022, of over 3000 students from all medical schools in Czechia. A particular focus was placed on respondents interested in paediatrics. Key findings include: (i) training experience plays a critical role in students’ career decisions; however, (ii) students report limited exposure to primary-care paediatrics during their studies; (iii) up to one-third of students who prefer paediatrics intend to leverage the flexibility facilitated by the reform and combine careers in primary-care and hospital-based paediatrics; (iv) family-work balance is a key consideration for students who prefer paediatrics; (v) support from employers during training and the quality of supervision are pivotal for choosing a medical facility. These insights into medical students’ career preferences are valuable for policy-makers internationally and underline the importance of aligning health workforce reforms with the preferences of medical graduates' and young physicians' to ensure an impact.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"154 ","pages":"Article 105259"},"PeriodicalIF":3.6,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143464782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Inequality in COVID-19 vaccine acceptance and uptake: A repeated cross-sectional analysis of COVID vaccine acceptance and uptake in 13 countries

IF 3.6 3区医学

Health Policy Pub Date : 2025-01-22 DOI: 10.1016/j.healthpol.2025.105251

Zachary DV Abel , Laurence SJ Roope , Raymond Duch , Sophie Cole , Philip M Clarke

{"title":"Inequality in COVID-19 vaccine acceptance and uptake: A repeated cross-sectional analysis of COVID vaccine acceptance and uptake in 13 countries","authors":"Zachary DV Abel , Laurence SJ Roope , Raymond Duch , Sophie Cole , Philip M Clarke","doi":"10.1016/j.healthpol.2025.105251","DOIUrl":"10.1016/j.healthpol.2025.105251","url":null,"abstract":"<div><div>Background COVID-19 vaccine hesitancy was a key barrier to ending the pandemic via mass immunisation.</div><div>Objectives Assess magnitudes and differences in socioeconomic inequality in stated COVID-19 vaccine acceptance (hesitancy) and uptake.</div><div>Methods Online surveys were conducted in 13 countries, collecting data from 15,337 and 18,189 respondents respectively. The investigation compares socioeconomic inequality in reported vaccine acceptance, measured in 2020–21 and subsequent uptake of vaccination in 2022. Inequalities are quantified using differences, ratios and the Erreygers adjusted concentration index. A regression decomposition approach is used to identify factors associated with inequality.</div><div>Results Mean uptake levels were 87 %, while acceptance was lower at 77 %. The difference between the richest and the poorest quintile was as large as 23 percentage points in acceptance and 30 p.p. in uptake, both observed in France. Acceptance and uptake were pro-rich (regressive) in most countries. Nine countries reported pro-rich inequality in acceptance, and eight in uptake. Uptake was significantly less regressive than acceptance in Australia, China, India, and USA. Australia and Colombia were the only countries where vaccination uptake was pro-poor (progressive). Age, marital status and political ideology were correlated with socioeconomic inequalities in several countries in both waves, while gender and education were associated with acceptance, and health levels with uptake.</div><div>Conclusion We found significant inequalities in vaccination acceptance and uptake across countries but inequality was generally lower in vaccine uptake than in acceptance. This suggests that inequalities can be reduced over time if adequate policies are in place to overcome hesitancy and reduce inequalities.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"153 ","pages":"Article 105251"},"PeriodicalIF":3.6,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143042531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Understanding private equity-owned HHAs in the U.S.: A performance comparison between pe-owned and non-pe-owned agencies

IF 3.6 3区医学

Health Policy Pub Date : 2025-01-22 DOI: 10.1016/j.healthpol.2025.105250

Mohammad Ishtiaque Rahman

{"title":"Understanding private equity-owned HHAs in the U.S.: A performance comparison between pe-owned and non-pe-owned agencies","authors":"Mohammad Ishtiaque Rahman","doi":"10.1016/j.healthpol.2025.105250","DOIUrl":"10.1016/j.healthpol.2025.105250","url":null,"abstract":"<div><h3>Background</h3><div>Private equity (PE) ownership in the healthcare sector has increased, raising concerns about its impact on care quality and patient outcomes. In the U.S., private equity-owned home health agencies (HHAs) make up a growing share of the market. This study aims to compare the performance of PE-owned HHAs with non-PE-owned agencies across several quality measures.</div></div><div><h3>Objective</h3><div>To assess the impact of PE ownership on care quality, patient outcomes, and operational efficiency in HHAs by comparing PE-owned and non-PE-owned agencies using data from Medicare-certified HHAs.</div></div><div><h3>Methods</h3><div>The study utilized data from the Centers for Medicare & Medicaid Services (CMS) Home Health Compare dataset, spanning 2017 to 2023. Fourteen quality and outcome measures were analyzed. Non-parametric tests, including the Mann-Whitney U test and Cliff's Delta, were used to identify significant differences between PE-owned and non-PE-owned HHAs.</div></div><div><h3>Results</h3><div>PE-owned HHAs generally outperformed non-PE-owned agencies in metrics such as timely care initiation and patient improvement in mobility and self-care. However, they underperformed in areas related to long-term outcomes, such as timely physician-recommended medication actions, preventable readmission rates, and discharge to the community.</div></div><div><h3>Conclusions</h3><div>PE-owned HHAs demonstrate greater efficiency and improvement in certain areas of patient care, but underperformance in critical long-term care outcomes raises concerns about the sustainability of care quality. Policymakers must carefully monitor the influence of PE ownership to ensure that improvements do not come at the expense of patient well-being.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"153 ","pages":"Article 105250"},"PeriodicalIF":3.6,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143030425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Classifying the WHO European countries by noncommunicable diseases and risk factors

IF 3.6 3区医学

Health Policy Pub Date : 2025-01-19 DOI: 10.1016/j.healthpol.2025.105247

Tevfik Bulut

{"title":"Classifying the WHO European countries by noncommunicable diseases and risk factors","authors":"Tevfik Bulut","doi":"10.1016/j.healthpol.2025.105247","DOIUrl":"10.1016/j.healthpol.2025.105247","url":null,"abstract":"<div><h3>Background</h3><div>In the twenty-first century, noncommunicable diseases (NCDs) are a major obstacle to global development and the accomplishment of the Sustainable Development Goals set forth by the United Nations. The WHO (World Health Organization) European Region lacks comprehensive understanding of NCD risk factors, the NCDs they trigger, and the more disadvantaged countries.</div></div><div><h3>Objective</h3><div>This study aims to classify the countries in the European Region at the country level based on NCDs and their key risk factors.</div></div><div><h3>Methods</h3><div>The Ward method, a hierarchical clustering technique based on Manhattan and Euclidean distance measures, was used. The study's dataset comes from the WHO's publicly available NCDs and key risk factors dataset.</div></div><div><h3>Results</h3><div>The European region's countries have been categorized into two clusters based on key NCD risk factors. The second cluster consists of countries with high income levels. On the other hand, in the European Region, countries fall into three clusters based on NCDs. Countries in the third cluster, which consists of low- and upper-middle-income countries, have lower average values in four variables compared to other countries, resulting in lower overall disease prevalence.</div></div><div><h3>Counclusions</h3><div>The prevalence of NCDs varies among clusters, with high-income countries having lower disease prevalence, particularly in diabetes and hypertension. Addressing risk factors and improving healthcare access and infrastructure are crucial in reducing the burden of NCDs in the European region.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"153 ","pages":"Article 105247"},"PeriodicalIF":3.6,"publicationDate":"2025-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143025677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The development of a discrete choice experiment: Investigating pharmacy selection in New Zealand

IF 3.6 3区医学

Health Policy Pub Date : 2025-01-15 DOI: 10.1016/j.healthpol.2025.105245

James Nind , Carlo A. Marra , Shane Scahill , Damien Mather , Alesha Smith

{"title":"The development of a discrete choice experiment: Investigating pharmacy selection in New Zealand","authors":"James Nind , Carlo A. Marra , Shane Scahill , Damien Mather , Alesha Smith","doi":"10.1016/j.healthpol.2025.105245","DOIUrl":"10.1016/j.healthpol.2025.105245","url":null,"abstract":"<div><h3>Introduction</h3><div>Discrete choice experiments (DCEs) provide a method for understanding preferences for service provision and there have been limited applications to the selection of community pharmacies. The validity and accuracy of DCEs rely upon the attributes and levels used. This paper aims to describe the development of a DCE investigating New Zealanders preferences for community pharmacies.</div></div><div><h3>Methods</h3><div>Five focus groups were conducted between August 2022 and April 2023, each representing a different demographic group. The transcripts underwent thematic analysis to develop themes and to write attributes that were important and realistic to participants. A complete survey combined choice tasks, generated through a partial factorial design, with demographic questions. It was pilot-tested using a ‘think aloud’ approach to ensure it was feasible and interpreted as intended.</div></div><div><h3>Results</h3><div>Thirty three codes were collated and refined into six attributes; location, wait time, customer service, prescription co-payments, nearby businesses, and car parking. Participants were asked to imagine they were in a new area, hence, attributes were presented as information available online.</div></div><div><h3>Discussion</h3><div>This in-depth reporting of DCE attribute development allows for robust evaluation of the validity of the processes used and identifies several differences.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"153 ","pages":"Article 105245"},"PeriodicalIF":3.6,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143030423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

How and why do health system factors influence general dentists’ participation in publicly funded, contracted primary dental care services: A realist review

IF 3.6 3区医学

Health Policy Pub Date : 2025-01-13 DOI: 10.1016/j.healthpol.2025.105248

Paul Leavy , Sophie Mulcahy Symmons , David Mockler , Pádraic Fleming , Blánaid Daly , John Ford , Sara Burke

{"title":"How and why do health system factors influence general dentists’ participation in publicly funded, contracted primary dental care services: A realist review","authors":"Paul Leavy , Sophie Mulcahy Symmons , David Mockler , Pádraic Fleming , Blánaid Daly , John Ford , Sara Burke","doi":"10.1016/j.healthpol.2025.105248","DOIUrl":"10.1016/j.healthpol.2025.105248","url":null,"abstract":"<div><h3>Objectives</h3><div>To identify health system contexts and mechanisms influencing general dental practitioners’ (GDPs) participation in state funded, contracted primary oral healthcare.</div></div><div><h3>Methods</h3><div>Peer-reviewed articles and other sources were identified via EMBASE, Medline (OVID), Web of Science and Google Scholar databases, grey literature search, citation tracking and expert recommendations. Studies meeting the inclusion criteria were assessed for rigour, relevance and richness, and coded to identify data relating to contexts, mechanisms and outcomes. Inductive and deductive coding was used to generate context–mechanism–outcome configurations (CMOCs) and develop the final programme theory.</div></div><div><h3>Results</h3><div>Database searching identified 1,844 articles of which 29 were included. A further 33 sources were identified through adjunctive searches. Analysis identified key systems contexts influencing GDP participation. These include system emphasis on treatment over prevention, low priority for oral healthcare, funding constraints, and change implementation with minimal clinician consensus. At operational level, contracts can restrict GDP decision-making and ability to deliver high quality and holistic patient care. Key underlying mechanisms were feelings of ceded clinical and entrepreneurial control, stress and demoralisation, mistrust of the system and feeling undervalued.</div></div><div><h3>Conclusions</h3><div>The factors influencing GDP participation in state-funded, contracted dental care over private dental care are complex. The findings presented in this review have the potential to act as a good place to start leveraging health system change including better GDP engagement and increase participation in publicly funded systems.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"153 ","pages":"Article 105248"},"PeriodicalIF":3.6,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143025683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

How COVID-19 illness perceptions and individual shocks are associated with trust during the COVID-19 pandemic in Australia, France, Germany, and South Africa 在澳大利亚、法国、德国和南非 COVID-19 大流行期间，COVID-19 疾病认知和个人冲击如何与信任相关联。

IF 3.6 3区医学

Health Policy Pub Date : 2025-01-01 DOI: 10.1016/j.healthpol.2024.105178

Marie-Hélène Broihanne , Daria Plotkina , Stefanie Kleimeier , Anja S. Göritz , Arvid O.I. Hoffmann

{"title":"How COVID-19 illness perceptions and individual shocks are associated with trust during the COVID-19 pandemic in Australia, France, Germany, and South Africa","authors":"Marie-Hélène Broihanne , Daria Plotkina , Stefanie Kleimeier , Anja S. Göritz , Arvid O.I. Hoffmann","doi":"10.1016/j.healthpol.2024.105178","DOIUrl":"10.1016/j.healthpol.2024.105178","url":null,"abstract":"<div><div>The COVID-19 pandemic jeopardized individuals’ health and economic stability, and the associated shocks might have decreased individuals’ trust. In this paper, we study the relationship between subjective perceptions of the pandemic and individuals’ institutional and interpersonal trust (e.g., trust towards the government or health representatives), while considering objective health and economic shocks due to the pandemic as drivers. We collected data across Australia, France, Germany, and South Africa during a later stage of the COVID-19 pandemic (i.e., from mid-April to early-June 2021) when individuals had time to personally experience the pandemic and its effects. COVID-19 illness perception was associated with lower institutional and interpersonal trust. The health shock of having experienced COVID-19 was associated with higher interpersonal trust, while economic shocks were associated with lower institutional trust when they were due to the pandemic. The results suggest that public policy interventions in a later stage of a pandemic should consider objective economic and health outcomes as well as subjective ones, such as individual's perceptions. Authorities should communicate in a way that helps concerned people understand that they can take control of their health and the possibility of infection, and reassure them that health measures such as vaccination can help prevent the spread of the virus.</div></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"151 ","pages":"Article 105178"},"PeriodicalIF":3.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0